ArticleDigestive diseases and sciences2022

Comparative Risk of Thrombotic and Cardiovascular Events with Tofacitinib and Anti-TNF Agents in Patients with Inflammatory Bowel Diseases.

Bharati D Kochar et al.PubMed ↗Publisher ↗

No numbers read from the abstract.